Domenico D'Amario, Giuseppe Ciliberti, Attilio Restivo, Renzo Laborante, Stefano Migliaro, Francesco Canonico, Giuseppe Massimo Sangiorgi, Matteo Tebaldi, Italo Porto, Daniele Andreini, Rocco Vergallo, Antonio Maria Leone, Salvatore Gervasi, Michela Cammarano, Vincenzo Palmieri, Francesco Burzotta, Carlo Trani, Paolo Zeppilli, Filippo Crea
Myocardial bridge (MB) is the most frequent inborn coronary artery variant in which a portion of the myocardium overlies an epicardial coronary artery segment. Although MB has long been considered a benign entity, a growing body of evidence has suggested its association with angina and adverse cardiac events. However, to date, no data on long-term prognosis are available, nor on therapies improving cardiovascular outcomes. We are currently conducting an ambispective, observational, multicentre, study in which we enrol patients with a clinical indication to undergo coronary angiography (CA) and evidence of MB, aiming to describe the incidence of symptoms and cardiovascular events at baseline and at long-term follow-up (FUP)...
November 2022: European Heart Journal Supplements: Journal of the European Society of Cardiology